AMOXICILLIN CAPSULES BP 500 MG
AMOXICILLIN (AMOXICILLIN TRIHYDRATE) : 500 MG · DIN 02525356 · SANIS HEALTH INC
Health Canada status: MARKETED
What is AMOXICILLIN CAPSULES BP?
AMOXICILLIN CAPSULES BP 500 MG contains AMOXICILLIN (AMOXICILLIN TRIHYDRATE) : 500 MG. It is listed in the Health Canada Drug Product Database under DIN 02525356, held by SANIS HEALTH INC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as marketed, status dated 03-Nov-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is AMOXICILLIN CAPSULES BP used for?
AMOXICILLIN CAPSULES BP (amoxicillin) may be indicated in the treatment of infections due to susceptible strains of various micro-organisms like Gram-negative (H. influenzae, P. mirabilis, N. gonorrhoeae) and Gram-positive (Streptococci including Streptococcus faecalis and Streptococcus pneumoniae). It is also indicated as a prophylaxis against alpha-hemolytic (Viridan's group) Streptococci before dental, oral or upper respiratory tract surgery or instrumentation, and for prophylaxis of bacterial endocarditis in patients with specific cardiac conditions.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02525356 |
|---|---|
| Brand name | AMOXICILLIN CAPSULES BP |
| Generic / active ingredient | AMOXICILLIN (AMOXICILLIN TRIHYDRATE) : 500 MG |
| Manufacturer | SANIS HEALTH INC |
| Strength | 500 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J01CA04 AMOXICILLIN |
| AHFS class | 08:12.16.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 03-Nov-2022 |
| Original market date | 2022-11-03 00:00:00 |
How is it stored and handled?
null
How is it supplied?
HDPE bottles of 100’s & 500’s count for 250 mg and 500 mg
Is AMOXICILLIN in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code J01CA04 AMOXICILLIN. 30 of 121 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AG-AMOXICILLIN | 250 MG / 5 ML | POWDER FOR SUSPENSION | ANGITA PHARMA INC. | MARKETED | DIN 02537451 |
| AG-AMOXICILLIN | 500 MG | CAPSULE | ANGITA PHARMA INC. | MARKETED | DIN 02477726 |
| AMOXICILLIN | 250 MG / 5 ML | GRANULES FOR SUSPENSION | SANIS HEALTH INC | MARKETED | DIN 02352788 |
| AMOXICILLIN | 250 MG / 5 ML | GRANULES FOR SUSPENSION | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02401541 |
| AMOXICILLIN | 250 MG / 5 ML | GRANULES FOR SUSPENSION | SANIS HEALTH INC | MARKETED | DIN 02352753 |
| AMOXICILLIN | 500 MG | CAPSULE | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02401509 |
| AMOXICILLIN CAPSULES BP | 250 MG | CAPSULE | SANIS HEALTH INC | MARKETED | DIN 02525348 |
| APO-AMOXI | 125 MG / 5 ML | POWDER FOR SUSPENSION | APOTEX INC | MARKETED | DIN 00628131 |
| APO-AMOXI | 250 MG | CAPSULE | APOTEX INC | MARKETED | DIN 00628115 |
| APO-AMOXI | 250 MG / 5 ML | POWDER FOR SUSPENSION | APOTEX INC | MARKETED | DIN 00628158 |
Who else supplies AMOXICILLIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. AMOXICILLIN appears in 3391 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.